These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 24357495

  • 21. Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin.
    Warrow DJ, Lai MM, Patel A, Raevis J, Berinstein DM.
    Am J Ophthalmol; 2015 Jan; 159(1):20-30.e1. PubMed ID: 25220823
    [Abstract] [Full Text] [Related]

  • 22. Delayed full-thickness macular hole closure without vitreomacular traction release following ocriplasmin injection.
    Abou Ltaif S, Herbert L.
    BMJ Case Rep; 2015 Sep 10; 2015():. PubMed ID: 26359463
    [Abstract] [Full Text] [Related]

  • 23. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.
    Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA, MIVI-TRUST Study Group.
    N Engl J Med; 2012 Aug 16; 367(7):606-15. PubMed ID: 22894573
    [Abstract] [Full Text] [Related]

  • 24. [Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole].
    Lenk J, Matthé E, Ventzke S, Pillunat LE, Sandner D.
    Klin Monbl Augenheilkd; 2018 Jan 16; 235(1):73-80. PubMed ID: 28282697
    [Abstract] [Full Text] [Related]

  • 25. [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences].
    Maier M, Abraham S, Frank C, Feucht N, Lohmann CP.
    Ophthalmologe; 2015 Dec 16; 112(12):990-4. PubMed ID: 26062717
    [Abstract] [Full Text] [Related]

  • 26. Predicting macular hole closure with ocriplasmin based on spectral domain optical coherence tomography.
    Steel DH, Parkes C, Papastavrou VT, Avery PJ, El-Ghrably IA, Habib MS, Sandinha MT, Smith J, Stannard KP, Vaideanu-Collins D, Hillier RJ.
    Eye (Lond); 2016 May 16; 30(5):740-5. PubMed ID: 26965018
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chronic Serous Macular Detachments and Visual Disturbance Complicating Consecutive Cases of Symptomatic Vitreomacular Adhesion With Macular Hole Treated With Ocriplasmin.
    Luttrull JK.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct 16; 46(9):976-8. PubMed ID: 26469240
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. EXPERIENCE WITH OCRIPLASMIN IN PATIENTS WITH VITREOMACULAR TRACTION SYNDROME: A RETROSPECTIVE STUDY OF 10 PATIENTS.
    Bormann C, Apitzsch BC, Habermann A, Hammer U, Hammer T.
    Retin Cases Brief Rep; 2020 Oct 16; 14(4):377-380. PubMed ID: 29621042
    [Abstract] [Full Text] [Related]

  • 33. Effect of ocriplasmin on the management of macular holes: assessment of the clinical relevance of ocriplasmin.
    Moisseiev J, Moroz I, Katz G.
    JAMA Ophthalmol; 2014 Jun 16; 132(6):709-13. PubMed ID: 24723009
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bilateral vitreomacular traction resolved with a single intravitreal ocriplasmin injection.
    Katz RS.
    Ophthalmic Surg Lasers Imaging Retina; 2014 Jun 16; 45(3):239-42. PubMed ID: 24708167
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Transient vision loss after ocriplasmin injection.
    Reiss B, Smithen L, Mansour S.
    Retina; 2015 Jun 16; 35(6):1107-10. PubMed ID: 25901839
    [Abstract] [Full Text] [Related]

  • 39. Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin.
    DeCroos FC, Toth CA, Folgar FA, Pakola S, Stinnett SS, Heydary CS, Burns R, Jaffe GJ.
    Invest Ophthalmol Vis Sci; 2012 Sep 21; 53(10):6504-11. PubMed ID: 22879421
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.